Phase 2 Study of Denosumab (IND#127430, NCS#744010), a RANK Ligand Antibody, for Recurrent or Refractory Osteosarcoma

Biotechnology Computer Science Energy Engineering Environmental Sciences Information Science Life Sciences Mathematics Medical Sciences

Military Sciences Natural Sciences Physical Sciences Plant Sciences Science Space Sciences Technology Transportation